transferred on share sale and purchase date from the seller’s connected persons ) and related services i.e. registration with Food and Drug Administration (FDA), trademark permission, product and packaging
. registration with Food and Drug Administration (FDA), trademark permission, product and packaging design, and brand building etc. to customers who are business operator in skin cares and cosmetics. In addition
granted a license from China Food and Drug Administration (CFDA) during the beginning of 2018 as the Company had to redesign and adjust product packaging according to the granted license as well as change
issued from China Food and Drug Administration (CFDA) at the beginning of 2018 as the Company had to redesign its packaging to comply with the requirements of the license and adjust its sales structures
, e.g., supermarket, food and restaurants (only for takeaway), drug stores. Online sales continued to grow remarkably by 150.0% YoY. Gross profit margin from sale of goods improved outstandingly to
, respectively. In 4Q’18, the company’s gross margin almost unchanged yoy. For year 2018, gross margin was 31% higher than 30% of year 2017. The improvement in gross margin was contributed by more revenue portion
planning and the improvement in the quality of goods, as well as improving and controlling the internal operational efficiency of the Company. During the second quarter, the Company continued to pursue its
world trade volume. In addition, tourism sector and the agricultural sector expanded continually, as well as improvement in public consumption and private investment. While, public investment declined. As
overall sales performance for the third quarter has improved from the previous quarter, especially in greater Bangkok and the big cities. This is in line with the improvement in the Thai economy, which has